IL1B and systemic-onset juvenile idiopathic arthritis: Further, sJIA is a heterogenous condition, and the role of IL-1 is less apparent in some patients [30, 34, 35]; indeed, Gattorno et al. identified two subsets of sJIA with distinct clinical features, based on (lack of) response to IL-1 blockade with anakinra.